Retinoblastoma protein expression in ovarian epithelial neoplasms

Gynecologic Oncology

Volumn 69, Issue 3, 1998, Pages 214-219

  Niemann, Theodore H ^a   Trgovac, Tracey L ^a   McGaughy, Violeta R ^a   Lewandowski, George S ^a   Copeland, Larry J ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Carcinoma; Cystadenoma; Low malignant potential; Ovary; Retinoblastoma

Indexed keywords

MONOCLONAL ANTIBODY; RETINOBLASTOMA PROTEIN;

ARTICLE; BRENNER TUMOR; CLEAR CELL CARCINOMA; CYSTADENOMA; ENDOMETRIOID CARCINOMA; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032104121     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5015     Document Type: Article

References (29)

1. Teneriello M G, Ebina M, Linnoila R I, Henry M, Nash J D, Park R C, Birrer M J. P53 and Ki-ras mutations in epithelial ovarian neoplasms. Cancer Res. 53:1993;3103-3108.
2. Inoue M, Fujita M, Enomoto T, Morimoto H, Monden T, Shimano T, Tanizawa O. Immunohistochemical analysis of p53 in gynecologic tumors. Am J Clin Pathol. 102:1994;665-670.
3. Skilling J S, Sood A, Niemann T, Lager D J, Buller R E. An abundance of p53 null mutations in ovarian carcinoma. Oncogene. 13:1996;117-123.
4. Santoso J T, Tang D-C, Lane S B, Hung J, Reed D J, Muller C Y, Carbone D P, Lucci J A III, Miller D S, Mathis J M. Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol. 59:1995;171-178.
5. Skilling J S, Squatrito R C, Connor J P, Niemann T, Buller R E. P53 gene mutation analysis and antisense-mediated growth inhibition of human ovarina carcinoma cell lines. Gynecol Oncol. 60:1996;72-80.
6. Boltz E M, Kefford R F, Leary J A, Houghton C R, Friedlander M L. Amplification of c-ras-Ki oncogene in human ovarian tumours. Int J Cancer. 43:1989;428-430.
7. Easton D F, Ford D, Bishop D T. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet. 56:1995;265-271.
8. Stratton J F, Gayther S A, Russell P, Dearden J, Gore M, Blake P, Easton D, Ponder B AJ. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med. 336:1997;1125-1130.
9. Murphree A L, Benedict W F. Retinoblastoma: clues for human oncogenesis. Science. 223:1984;1028-1033.
10. Xu H-J. Altered retinoblastma (RB) protein expression in human malignancies. Adv Anatom Pathol. 2:1995;213-226.
11. Friend S H, Bernards R, Rogelj S, Weinberg R A, Rapaport J M, Albert D M, Dryja T P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
12. Ishikawa J, Xu H-J, Hu S-X, Yandell D W, Maeda S, Kamidono S, Benedict W F, Takahashi R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res. 51:1991;5736-5743.
13. Presti J C, Reuter V E, Galan T, Fair W R, Cordon-Carso C. Molecular genetic alterations in superficial and locally advanced bladder cancer. Cancer Res. 51:1991;5405-5409.
14. Yokota J, Akiyama T, Fung Y-K T. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene. 3:1988;471-473.
15. Xu H-J, Hu S-X, Cagle P T, Moore G E, Benedict W F. Absence of retinoblastoma-protein expression in primary non-small-cell lung carcinomas. Cancer Res. 51:1991;2735-2739.
16. Lee E Y-HP, To H, Shew J-Y, Bookstein R, Scully P, Lee W-H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science. 241:1988;218-221.
17. Bookstein R, Rio P, Madreperla S A. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA. 87:1990;7762-7766.
18. Zhang X, Xu H-J, Murahami Y, Sachse R, Yashima K, Hirohashi S, Hu S-X, Benedict W F, Sekiya T. Deletions of chromosome 13q mutations in RB1 and RB protein state, in human hepatocellular carcinoma. Cancer Res. 54:1994;4177-4182.
19. Enomoto T, Fujita M, Inoue M, Nakazawa-Miyamoto A, Tanizawa O, Nomura T. Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma. Mol Carcinog. 8:1993;132-137.
20. Niemann T H, Yilmaz A G, McGaughy V R, Vaccarello L. Retinoblastoma protein expression in endometrial hyperplasia and carcinoma. Gynecol Oncol. 65:1997;232-236.
21. Sasano H, Comerford J, Silverberg S G, Garrett C T. An analysis of abnormalities of the retinoblastoma gene in human ovarian and endometrial carcinoma. Cancer. 66:1990;2150-2154.
22. Geradts J, Kratzke R A, Crush-Stanton S, Wen S F, Lincoln C E. Wild-type and mutant retinoblastoma protein in paraffin sections. Mod Pathol. 9:1996;339-347.
23. Shimizu E, Coxon A, Otterson G A, Steinberg S M, Kratzke R A, Kim Y W, Fedorko J, Oie H, Johnson B E, Mulshine J L, Minna J D, Gazdar A F, Kaye F J. RB protein status and clinical correltation from 171 cell lines representing lung cancer, extrapulomonary small cell carcinoma, and mesothelioma. Oncogene. 9:1994;2441.
24. J, A, Benda, GOG Pathology Manual.
25. Geradts J, Hu S-X, Lincoln C E, Benedict W F, Xu H-J. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer. 58:1994;161-167.
26. Dodson M K, Cliby W A, Xu H-J, DeLacey K A, Hu S-X, Keeney G L, Li J, Podratz K C, Jenkins R B, Benedict W F. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res. 54:1994;610-613.
27. Kim T M, Benedict W F, Xu H-J, Hu S-X, Gosewehr J, Velicescu M, Yin E, Zheng J, D'Ablaing G, Dubeau L. Loss of heterozygosity on chromosome 13 is common only in biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Res. 54:1994;605-609.
28. Taylor R R, Linnoila R I, Gerardts J, Teneriello M G, Nash J D, Park R C, Birrer M J. Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations. Gynecol Oncol. 58:1995;307-311.
29. Cordon-Cardo C, Richon V M. Expression of the retinoblastoma protein is regulated in normal tissues. Am J Pathol. 144:1994;500-510.